243 evolution "https:" "https:" "https:" "UCL" "UCL" positions at University of London
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
accordance with the Immigration, Asylum and Nationality Act 2006. Applications are invited for the post of New Business Development Manager in the Commercial Services team. Royal Holloway has a robust
-
About the Role We are seeking an experienced Methods Advisor to join the QMUL arm of the NIHR Research Support Service (RSS) Hub delivered by Imperial College London and Partners (QMUL, UCL and
-
Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. About Queen Mary At Queen Mary University of London, we believe that a diversity of
-
clinician scientists to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre
-
City of London Major Centre (together with UCL, King’s and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. BCI is committed in supporting and developing future cancer
-
schools and meetings. We are looking to expand our commercial business through the development of new business types. We see the focus being on developing events that can be ticketed to the general public
-
will be based in the MRC/UVRI and LSHTM Uganda Research Unit, with very close project connections with the International Centre for Eye Health at LSHTM, Makerere University and UCL Institute
-
software engineering activities, fostering knowledge exchange and collaboration within the RSE community at the college and beyond. Alongside enhancing the team's development methodologies, you will
-
schools and meetings. We are looking to expand our commercial business through the development of new business types. We see the focus being on developing events that can be ticketed to the general public
-
will develop the mathematical/computational tool-box to describe the evolution of ecDNA and test predictions of these theories in existing and newly generated cancer genomic data. The position will be